Drug treatment of acute vertigo

Author:

Masueva S. S.1,Zamergrad M. V.2

Affiliation:

1. Russian Medical Academy for Continuing Professional Education

2. Pirogov Russian National Research Medical University

Abstract

Acute vertigo is a severe condition that requires urgent treatment. Vertigo can be caused by peripheral or central vestibular disorders of various etiopathology. Whatever the reason of vestibular dizziness, it is characterized by severe attacks with imbalance, nausea and vomiting in the acute period. Symptomatic treatment consists of vestibular suppressants and antiemetic drugs. There are several key principles regarding management of patients with vertigo that includes combined use of vestibular suppressants and antiemetics, which allows potentiation of their effects, limitation the use of symptomatic therapy to 2–3 days and perhaps earlier initiation of vestibular rehabilitation which effectiveness can be improved with agents that stimulate central vestibular adaptation.

Publisher

Alfmed LLC

Subject

Materials Chemistry,Economics and Econometrics,Media Technology,Forestry

Reference36 articles.

1. Zamergrad M. V., Parfenov V. A., Morozova S. V. i dr. Perifericheskie vestibulyarnye rasstroistva v ambulatornoi praktike. Vestnik otorinolaringologii. 2017; 82 (1): 30–33.

2. Brandt T., Diterikh M., Shtrupp M. Golovokruzhenie. M.: Praktika; 2009.

3. Smith P. F., Darlington C. L. Recent advances in the pharmacology of the vestibulo-ocular reflex system. Trends in Pharmacological Sciences. 1996 Nov; 17 (11): 421–427.

4. De Waele C., Mühlethaler M., Vidal P. P. Neurochemistry of the central vestibular pathways. Brain Research Reviews. 1995; 20 (1), 24–46.

5. Barton J. J.S., Huaman A. G., Sharpe J. A. Muscarinic antagonists in the treatment of acquired pendular and downbeat nystagmus: A double-blind, randomized trial of three intravenous drugs. Annals of Neurology. 1994; 35 (3), 319–325.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3